Cancer Investigation

Journal Title：Cancer Investigation

Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.

Cancer Investigation 是基础和临床肿瘤学领域最受推崇和认可的期刊之一。它旨在为医生提供有关癌症领域当前进展状态的综合资源，以及有效决策所需的可靠信息的广泛背景。除了发表具有根本意义的原创论文外，它还发表评论、论文、争议的专门演讲、新技术的思考及其在特定实验室问题中的应用、公共问题的讨论、重大主题的迷你剧、新的和实验性的药物和疗法，以及给编辑部分的创新信件。该期刊的独特之处之一是其部门化的编辑部分报道了 30 多个学科类别，涵盖了共同构成肿瘤学领域的广泛专业领域。这些部分由领先的医生和研究科学家编辑，使癌症调查成为临床医生寻求理解整个领域中有时压倒性的大量信息的主要资源。除了经过同行评审的临床研究外，该杂志还收录了弥合实验室和临床之间差距的转化研究。

Cancer Investigation创刊于1983年，由TAYLOR & FRANCIS INC出版商出版，收稿方向涵盖医学 - 肿瘤学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度约8.5月，影响因子指数2.398，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。